Stereotactic radiation may offer better outcomes in nine cancersOctober 24, 2019New data suggests a specific advanced radiation treatment protocol is leading to better survival outcomes than other therapy options for at least nine tumor types. That’s according to PetCure Oncology, which presented its findings at the recent Veterinary Cancer Society Annual Conference (VCS) in Houston, Tex. The pet cancer care provider says nine of the 11 tumor types it studied showed increased median survival time relative to the current body of peer-reviewed published literature …
SPONSORED CONTENTControl canine osteoarthritis at the sourceEffective inflammation and pain management is possible for your canine osteoarthritis patients. + Discover How
PetCure Oncology marks 3,000 cancer treatmentsSeptember 26, 2019Cancer care company PetCure Oncology hit a milestone this week with the treatment of its 3,000th patient.
Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
PetCure Oncology plans 30 hospitalsJuly 28, 2016PetCure Oncology, which rolled out stereotactic radiosurgery for cancer-stricken pets just over a year ago, has big expansion plans.
